Ten years back, only about 25% of U. S. adults could list the three branches of government. Now that number has jumped to 70%. The question isn’t why fewer people know this today—it’s why more people know it now compared to before. Over the last decade, civic education quietly became a quiet superpo
Russia and China’s relationship keeps growing in ways that go far beyond oil and trade. Officials in Moscow highlight education and technology as key parts of their partnership. This goes against the idea that the two countries only work together because of pressure from the West. Their cooperation
Some of the best crime films feel real because their heists aren’t just flashy set pieces—they’re carefully planned. These scenes make you root for the criminals even though what they're doing is illegal. Over decades, directors have experimented with different ways to pull off robberies on screen.
San Francisco''s recent crime wave has roots in a surprising place: the courtroom. Last month, the state''s top judges ruled that bail amounts for so-called non-violent crimes must be affordable enough for almost anyone to pay. This sounds fair on paper, but in practice it means repeat offenders are
Banks today look nothing like they did even five years ago. What used to be slow, paperwork-heavy processes are now running on smart software. AI isn’t just helping banks—it’s doing much of the work itself. These "agentic" AI systems don’t just follow instructions; they make decisions on the spot, w
How are life-saving treatments chosen? When governments decide which medicines to evaluate, they often overlook rare diseases. Most health plans focus on treatments that help large groups, leaving small patient communities behind. Rare disease drugs, called orphan medicinal products, rarely get fair
A recent Senate roadblock threatens to derail Republican efforts to funnel $1 billion into the White House ballroom project, raising questions about how public money gets spent on presidential whims. A top Senate official ruled that the funding proposal stretches beyond the usual budget rules, forci
AI isn’t replacing doctors, but it’s becoming a helpful tool in cancer care. A big study looked at how AI helps with something called "organ at risk contouring" – basically drawing clear maps around healthy parts of the body that shouldn’t get too much radiation during treatment. These maps are cruc
IIFL Finance closed last week at INR464. 85 per share, but one analyst isn’t convinced it’s time to buy. Bhaskar Basu, who follows financial stocks like HDB Financial and Muthoot Finance, kept a Hold rating and set a target of INR520. 00. That’s a nearly 12% jump from the current price. But is this
A major financial firm just confirmed its confidence in a big Chinese lifestyle company. The firm raised its forecast for the company’s future stock price to roughly HK$63. 60 per share, suggesting now might be a good time to buy. Other analysts seem to agree, with most marking the company as a soli
